Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07736690) titled 'Perioperative Topical Nepafenac After Epiretinal Membrane Surgery' on July 27.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Ankara Yildirim Beyazit University
Condition:
Epiretinal Membrane
Macular Pucker
Intervention:
Drug: Nepafenac 0.1% Ophthalmic Suspension
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: January 1, 2024
Target Sample Size: 60
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/stud...